Cargando…

Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe

Antibodies to Plasmodium falciparum are specific biomarkers that can be used to monitor parasite exposure over broader time frames than microscopy, rapid diagnostic tests, or molecular assays. Consequently, seroprevalence surveys can assist with monitoring the impact of malaria control interventions...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Tamaki, Jain, Aarti, Liang, Li, Obiero, Joshua M., Hamapumbu, Harry, Stevenson, Jennifer C., Thuma, Philip E., Lupiya, James, Chaponda, Mike, Mulenga, Modest, Mamini, Edmore, Mharakurwa, Sungano, Gwanzura, Lovemore, Munyati, Shungu, Mutambu, Susan, Felgner, Philip, Davies, D. Huw, Moss, William J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437277/
https://www.ncbi.nlm.nih.gov/pubmed/30918058
http://dx.doi.org/10.1128/mSphereDirect.00061-19
_version_ 1783406931692486656
author Kobayashi, Tamaki
Jain, Aarti
Liang, Li
Obiero, Joshua M.
Hamapumbu, Harry
Stevenson, Jennifer C.
Thuma, Philip E.
Lupiya, James
Chaponda, Mike
Mulenga, Modest
Mamini, Edmore
Mharakurwa, Sungano
Gwanzura, Lovemore
Munyati, Shungu
Mutambu, Susan
Felgner, Philip
Davies, D. Huw
Moss, William J.
author_facet Kobayashi, Tamaki
Jain, Aarti
Liang, Li
Obiero, Joshua M.
Hamapumbu, Harry
Stevenson, Jennifer C.
Thuma, Philip E.
Lupiya, James
Chaponda, Mike
Mulenga, Modest
Mamini, Edmore
Mharakurwa, Sungano
Gwanzura, Lovemore
Munyati, Shungu
Mutambu, Susan
Felgner, Philip
Davies, D. Huw
Moss, William J.
author_sort Kobayashi, Tamaki
collection PubMed
description Antibodies to Plasmodium falciparum are specific biomarkers that can be used to monitor parasite exposure over broader time frames than microscopy, rapid diagnostic tests, or molecular assays. Consequently, seroprevalence surveys can assist with monitoring the impact of malaria control interventions, particularly in the final stages of elimination, when parasite incidence is low. The protein array format to measure antibodies to diverse P. falciparum antigens requires only small sample volumes and is high throughput, permitting the monitoring of malaria transmission on large spatial and temporal scales. We expanded the use of a protein microarray to assess malaria transmission in settings beyond those with a low malaria incidence. Antibody responses in children and adults were profiled, using a P. falciparum protein microarray, through community-based surveys in three areas in Zambia and Zimbabwe at different stages of malaria control and elimination. These three epidemiological settings had distinct serological profiles reflective of their malaria transmission histories. While there was little correlation between transmission intensity and antibody signals (magnitude or breadth) in adults, there was a clear correlation in children younger than 5 years of age. Antibodies in adults appeared to be durable even in the absence of significant recent transmission, whereas antibodies in children provided a more accurate picture of recent levels of transmission intensity. Seroprevalence studies in children could provide a valuable marker of progress toward malaria elimination. IMPORTANCE As malaria approaches elimination in many areas of the world, monitoring the effect of control measures becomes more important but challenging. Low-level infections may go undetected by conventional tests that depend on parasitemia, particularly in immune individuals, who typically show no symptoms of malaria. In contrast, antibodies persist after parasitemia and may provide a more accurate picture of recent exposure. Only a few parasite antigens—mainly vaccine candidates—have been evaluated in seroepidemiological studies. We examined antibody responses to 500 different malaria proteins in blood samples collected through community-based surveillance from areas with low, medium, and high malaria transmission intensities. The breadth of the antibody responses in adults was broad in all three settings and was a poor correlate of recent exposure. In contrast, children represented a better sentinel population for monitoring recent malaria transmission. These data will help inform the use of multiplex serology for malaria surveillance.
format Online
Article
Text
id pubmed-6437277
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-64372772019-04-03 Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe Kobayashi, Tamaki Jain, Aarti Liang, Li Obiero, Joshua M. Hamapumbu, Harry Stevenson, Jennifer C. Thuma, Philip E. Lupiya, James Chaponda, Mike Mulenga, Modest Mamini, Edmore Mharakurwa, Sungano Gwanzura, Lovemore Munyati, Shungu Mutambu, Susan Felgner, Philip Davies, D. Huw Moss, William J. mSphere Research Article Antibodies to Plasmodium falciparum are specific biomarkers that can be used to monitor parasite exposure over broader time frames than microscopy, rapid diagnostic tests, or molecular assays. Consequently, seroprevalence surveys can assist with monitoring the impact of malaria control interventions, particularly in the final stages of elimination, when parasite incidence is low. The protein array format to measure antibodies to diverse P. falciparum antigens requires only small sample volumes and is high throughput, permitting the monitoring of malaria transmission on large spatial and temporal scales. We expanded the use of a protein microarray to assess malaria transmission in settings beyond those with a low malaria incidence. Antibody responses in children and adults were profiled, using a P. falciparum protein microarray, through community-based surveys in three areas in Zambia and Zimbabwe at different stages of malaria control and elimination. These three epidemiological settings had distinct serological profiles reflective of their malaria transmission histories. While there was little correlation between transmission intensity and antibody signals (magnitude or breadth) in adults, there was a clear correlation in children younger than 5 years of age. Antibodies in adults appeared to be durable even in the absence of significant recent transmission, whereas antibodies in children provided a more accurate picture of recent levels of transmission intensity. Seroprevalence studies in children could provide a valuable marker of progress toward malaria elimination. IMPORTANCE As malaria approaches elimination in many areas of the world, monitoring the effect of control measures becomes more important but challenging. Low-level infections may go undetected by conventional tests that depend on parasitemia, particularly in immune individuals, who typically show no symptoms of malaria. In contrast, antibodies persist after parasitemia and may provide a more accurate picture of recent exposure. Only a few parasite antigens—mainly vaccine candidates—have been evaluated in seroepidemiological studies. We examined antibody responses to 500 different malaria proteins in blood samples collected through community-based surveillance from areas with low, medium, and high malaria transmission intensities. The breadth of the antibody responses in adults was broad in all three settings and was a poor correlate of recent exposure. In contrast, children represented a better sentinel population for monitoring recent malaria transmission. These data will help inform the use of multiplex serology for malaria surveillance. American Society for Microbiology 2019-03-27 /pmc/articles/PMC6437277/ /pubmed/30918058 http://dx.doi.org/10.1128/mSphereDirect.00061-19 Text en Copyright © 2019 Kobayashi et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Kobayashi, Tamaki
Jain, Aarti
Liang, Li
Obiero, Joshua M.
Hamapumbu, Harry
Stevenson, Jennifer C.
Thuma, Philip E.
Lupiya, James
Chaponda, Mike
Mulenga, Modest
Mamini, Edmore
Mharakurwa, Sungano
Gwanzura, Lovemore
Munyati, Shungu
Mutambu, Susan
Felgner, Philip
Davies, D. Huw
Moss, William J.
Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe
title Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe
title_full Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe
title_fullStr Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe
title_full_unstemmed Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe
title_short Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe
title_sort distinct antibody signatures associated with different malaria transmission intensities in zambia and zimbabwe
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437277/
https://www.ncbi.nlm.nih.gov/pubmed/30918058
http://dx.doi.org/10.1128/mSphereDirect.00061-19
work_keys_str_mv AT kobayashitamaki distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT jainaarti distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT liangli distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT obierojoshuam distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT hamapumbuharry distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT stevensonjenniferc distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT thumaphilipe distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT lupiyajames distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT chapondamike distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT mulengamodest distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT maminiedmore distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT mharakurwasungano distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT gwanzuralovemore distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT munyatishungu distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT mutambususan distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT felgnerphilip distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT daviesdhuw distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe
AT mosswilliamj distinctantibodysignaturesassociatedwithdifferentmalariatransmissionintensitiesinzambiaandzimbabwe